Geode Capital Management, LLC Eiger Bio Pharmaceuticals, Inc. Transaction History

Geode Capital Management, LLC

$1.21 Trillion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$0.28 - $0.93 $85 - $285	307 Added 0.08%	379,707 $113,000
Q2 2023 Aug 11, 2023	SELL	$0.55 - $1.26 $224,584 - $514,502	-408,335 Reduced 51.84%	379,400 $265,000
Q1 2023 May 15, 2023	BUY	$0.89 - $2.52 $24,410 - $69,118	27,428 Added 3.61%	787,735 $708,000
Q4 2022 Feb 13, 2023	BUY	$1.02 - $7.48 $23,285 - $170,760	22,829 Added 3.1%	760,307 $897,000
Q3 2022 Nov 14, 2022	BUY	$6.04 - $9.66 $277,894 - $444,446	46,009 Added 6.65%	737,478 $5.55 Million
Q2 2022 Aug 12, 2022	BUY	$4.99 - $8.96 $278,931 - $500,846	55,898 Added 8.79%	691,469 $4.36 Million
Q1 2022 May 13, 2022	BUY	$3.84 - $9.74 $99,002 - $251,116	25,782 Added 4.23%	635,571 $5.28 Million
Q4 2021 Feb 11, 2022	BUY	$5.12 - $8.19 $10,219 - $16,347	1,996 Added 0.33%	609,789 $3.16 Million
Q3 2021 Nov 12, 2021	BUY	$6.68 - $9.1 $62,518 - $85,166	9,359 Added 1.56%	607,793 $4.06 Million
Q2 2021 Aug 13, 2021	BUY	$7.82 - $9.23 $292,655 - $345,423	37,424 Added 6.67%	598,434 $5.1 Million
Q1 2021 May 12, 2021	BUY	$8.44 - $12.66 $835,931 - $1.25 Million	99,044 Added 21.44%	561,010 $4.96 Million
Q4 2020 Feb 12, 2021	BUY	$7.98 - $12.29 $563,244 - $867,452	70,582 Added 18.03%	461,966 $5.68 Million
Q3 2020 Nov 13, 2020	BUY	$7.96 - $12.42 $328,222 - $512,126	41,234 Added 11.78%	391,384 $3.19 Million
Q2 2020 Aug 13, 2020	BUY	$5.4 - $13.37 $134,605 - $333,273	24,927 Added 7.66%	350,150 $3.36 Million
Q1 2020 May 14, 2020	BUY	$4.91 - $14.7 $110,730 - $331,514	22,552 Added 7.45%	325,223 $2.21 Million
Q4 2019 Feb 13, 2020	BUY	$9.77 - $15.66 $90,001 - $144,259	9,212 Added 3.14%	302,671 $4.51 Million
Q3 2019 Nov 12, 2019	BUY	$9.59 - $12.0 $40,402 - $50,556	4,213 Added 1.46%	293,459 $3.01 Million
Q2 2019 Aug 14, 2019	BUY	$9.54 - $14.96 $1.59 Million - $2.49 Million	166,338 Added 135.34%	289,246 $3.07 Million
Q1 2019 May 14, 2019	BUY	$10.31 - $14.38 $186,775 - $260,508	18,116 Added 17.29%	122,908 $1.72 Million
Q4 2018 Feb 13, 2019	BUY	$8.63 - $12.4 $234,183 - $336,486	27,136 Added 34.94%	104,792 $1.06 Million
Q2 2018 Aug 14, 2018	BUY	$8.3 - $16.8 $452,906 - $916,725	54,567 Added 236.33%	77,656 $947,000
Q2 2017 Aug 14, 2017	BUY	N/A	23,089	23,089 $182,000

Others Institutions Holding EIGR

# of Institutions

Shares Held

748K

Call Options Held

Put Options Held

View Full List

About Eiger BioPharmaceuticals, Inc.

Ticker EIGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,966,800
Market Cap $418M
Description
Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trials to ...

More about EIGR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account